Chugai Pharmaceutical Co Ltd
TSE:4519

Watchlist Manager
Chugai Pharmaceutical Co Ltd Logo
Chugai Pharmaceutical Co Ltd
TSE:4519
Watchlist
Price: 8 470 JPY -1.74% Market Closed
Market Cap: 14.2T JPY

Intrinsic Value

The intrinsic value of one Chugai Pharmaceutical Co Ltd stock under the Base Case scenario is 4 934.74 JPY. Compared to the current market price of 8 470 JPY, Chugai Pharmaceutical Co Ltd is Overvalued by 42%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
4 934.74 JPY
Overvaluation 42%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Chugai Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Chugai Pharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Chugai Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Chugai Pharmaceutical Co Ltd
TSE:4519
JP
Pharmaceuticals
Market Cap
13.9T JPY
IPO
Mar 3, 1956
JP
Pharmaceuticals
Market Cap
13.9T JPY
IPO
Mar 3, 1956
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Chugai Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Chugai Pharmaceutical Co Ltd

Current Assets 1.6T
Cash & Short-Term Investments 996.3B
Receivables 335.2B
Other Current Assets 274.5B
Non-Current Assets 602.3B
Long-Term Investments 16.6B
PP&E 441.6B
Intangibles 17.9B
Other Non-Current Assets 126.3B
Efficiency

Free Cash Flow Analysis
Chugai Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Chugai Pharmaceutical Co Ltd

Revenue
1.2T JPY
Cost of Revenue
-354.3B JPY
Gross Profit
867.8B JPY
Operating Expenses
-289.1B JPY
Operating Income
578.8B JPY
Other Expenses
-168.6B JPY
Net Income
410.1B JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Chugai Pharmaceutical Co Ltd's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Year Average ROE
73/100
Profitability
Score

Chugai Pharmaceutical Co Ltd's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Chugai Pharmaceutical Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Chugai Pharmaceutical Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Chugai Pharmaceutical Co Ltd

Wall Street analysts forecast Chugai Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Chugai Pharmaceutical Co Ltd is 8 527.93 JPY with a low forecast of 6 161 JPY and a high forecast of 12 180 JPY.

Lowest
Price Target
6 161 JPY
27% Downside
Average
Price Target
8 527.93 JPY
1% Upside
Highest
Price Target
12 180 JPY
44% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Chugai Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Chugai Pharmaceutical Co Ltd stock?

The intrinsic value of one Chugai Pharmaceutical Co Ltd stock under the Base Case scenario is 4 934.74 JPY.

Is Chugai Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 8 470 JPY, Chugai Pharmaceutical Co Ltd is Overvalued by 42%.

Back to Top